View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Bevacizumab 15 / Paclitaxel 80 / Doxorubicin Liposomal 20 / Carboplatin 1.5, Breast Cancer, tripel-negative
Protocol-ID: 754 V1.2 (Mini), BEVA15/PACL80/LDOX20/CRBP1.5, Breast Ca (tripel-neg.)Indication(s)
- Breast Cancer (tripel negative); ICD-10 C50.-
Links
- One-hour paclitaxel infusions: review of safety and efficacy. [PMID]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 01.04.2020